Skip to Main content Skip to Navigation
Journal articles

The Decline of the Experimental Paradigm During the COVID-19 Pandemic: A Template for the Future

Abstract : The current Coronavirus Disease 2019 (COVID-19) pandemic has exerted an unprecedented impact across the globe. As a consequence of this overwhelming catastrophe, long-established prevailing medical and scientific paradigms have been disrupted. The response of the scientific community, medical journals, media, and some politicians has been far from ideal. The present manuscript discusses the failure of the scientific enterprise in its initiatives to address the COVID-19 outbreak as a consequence of the disarray attributable to haste and urgency. To enhance conveying our message, this manuscript is organized into 3 interrelated sections: 1) the accelerated pace of publications coupled with a dysfunctional review process; 2) failure of the clinical trial enterprise; 3) propagation of misleading information by the media. In response we propose a template comprising a focus on randomized controlled clinical trials, and an insistence on responsible journal publication, and enumeration of policies to deal with social media-propagated news. We conclude with a reconsideration of the appropriate role of academic medicine and journals.
Complete list of metadatas

Cited literature [67 references]  Display  Hide  Download

https://hal.univ-lorraine.fr/hal-03007932
Contributor : Erwan Bozec <>
Submitted on : Thursday, November 19, 2020 - 11:13:20 AM
Last modification on : Friday, November 20, 2020 - 3:32:03 AM

Files

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2021-03-01

Please log in to resquest access to the document

Identifiers

Collections

Citation

João Ferreira, Murray Epstein, Faiez Zannad. The Decline of the Experimental Paradigm During the COVID-19 Pandemic: A Template for the Future. The American Journal of Medicine, Elsevier [Commercial Publisher] 2020, ⟨10.1016/j.amjmed.2020.08.021⟩. ⟨hal-03007932⟩

Share

Metrics

Record views

3